Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « MeshFr.i » - entrée « Polyarthrite rhumatoïde »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Polyangéite microscopique < Polyarthrite rhumatoïde < Polyartérite noueuse  Facettes :

List of bibliographic references indexed by Polyarthrite rhumatoïde

Number of relevant bibliographic references: 1059.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000888 (2019) Michael D. George ; Joshua F. Baker ; Kevin Winthrop [États-Unis] ; Evo Alemao ; Lang Chen ; Sean Connolly ; Jesse Y. Hsu ; Teresa A. Simon ; Qufei Wu ; Fenglong Xie ; Shuo Yang ; Jeffrey R. CurtisRisk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study.
000892 (2019) Kenji Oku [Japon] ; Tatsuya Atsumi [Japon]Rheumatology practice in Japan: challenges and opportunities.
000894 (2019) Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000895 (2019) Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France]Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis.
000899 (2019) Ryuki Sakaguchi [Japon] ; Keita Fujikawa [Japon] ; Momoko Okamoto [Japon] ; Emi Matsuo [Japon] ; Kohei Matsumoto [Japon] ; Tomohisa Uchida [Japon] ; Kawashiri Shin-Ya [Japon] ; Masahiro Nakashima [Japon] ; Akinari Mizokami [Japon] ; Atsushi Kawakami [Japon]Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder
000902 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.
000914 (2019) Takafumi Naito [Japon] ; Junya Ohshiro [Japon] ; Hikaru Sato [Japon] ; Eiji Torikai [Japon] ; Motohiro Suzuki [Japon] ; Noriyoshi Ogawa [Japon] ; Junichi Kawakami [Japon]Relationships between concomitant biologic DMARDs and prednisolone administration and blood tacrolimus exposure or serum CYP3A4/5-related markers in rheumatoid arthritis patients.
000925 (2019) Raimon Sanmarti [Espagne] ; Douglas J. Veale [Irlande (pays)] ; Emilio Martin-Mola [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Carlos González [Espagne] ; Liliana Ercole [Espagne] ; Rocío Alonso [Espagne] ; João E. Fonseca [Portugal]Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial.
000954 (2019) Diederik De Cock [Belgique] ; Patrick Verschueren [Belgique]Primus inter pares: the choice of biologic drugs in rheumatoid arthritis.
000966 (2019) Meghna Jani [Royaume-Uni] ; Anne Barton [Royaume-Uni] ; Kimme Hyrich [Royaume-Uni]Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
000976 (2019) Yannick Degboé [France] ; Benjamin Rauwel [France] ; Michel Baron [France] ; Jean-Frédéric Boyer [France] ; Adeline Ruyssen-Witrand [France] ; Arnaud Constantin [France] ; Jean-Luc Davignon [France]Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
000979 (2019) Yoshifumi Tada [Japon] ; Mariko Sakai [Japon] ; Yoshinobu Nakao [Japon] ; Akihito Maruyama [Japon] ; Nobuyuki Ono [Japon] ; Syuichi Koarada [Japon]Placental transfer of tocilizumab in a patient with rheumatoid arthritis.
000988 (2019) María Ngeles González-Fernández [Espagne] ; Elena Villama N [Espagne] ; Inmaculada Jiménez-Nácher [Espagne] ; Francisco Moreno [Espagne] ; Alicia Herrero [Espagne] ; Alejandro Balsa [Espagne]Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients.
000A29 (2019) G. Carlino [Italie] ; M. Fornaro ; L. Santo ; R. Bucci ; A. Semeraro ; L. Quarta ; F. D'Onofrio ; A. Marsico ; C. Zuccaro ; P C Falappone ; D. Mazzotta ; F P Cantatore ; M. Muratore ; F. IannoneOccult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).
000A50 (2019) Manuel Camean-Castillo [Espagne] ; Vicente Gimeno-Ballester [Espagne] ; Esmeralda Rios-Sanchez [Espagne] ; Silvia Fenix-Caballero [Espagne] ; Miguel Vázquez-Real [Espagne] ; Emilio Alegre-Del Rey [Espagne]Network meta-analysis of tofacitinib versus biologic treatments in moderate-to-severe rheumatoid arthritis patients.
000B11 (2019) Atsushi Ogata [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Motohide Kaneko [Japon] ; Hiroko Miwa [Japon] ; Shino Ohsawa [Japon] ; Reiji Yamakawa [Japon]Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study.
000B13 (2019) Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000B28 (2019) Abrar-Ahmad Zulfiqar [France] ; Rizwan Niazi [France] ; Jean-Loup Pennaforte [France] ; Emmanuel Andres [France]Late-onset rheumatoid arthritis: clinical, biological, and therapeutic features About a retrospective study.
000B65 (2019) Maxime Ma Verhoeven [Pays-Bas] ; Marjolein Jh De Hair [Pays-Bas] ; Janneke Tekstra [Pays-Bas] ; Johannes Wj Bijlsma [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Attila Pethoe-Schramm [Suisse] ; Michelle Ea Borm [Pays-Bas] ; Evert-Jan Ter Borg [Pays-Bas] ; Suzanne P. Linn-Rasker [Pays-Bas] ; Xavier M. Teitsma [Pays-Bas] ; Floris Pjg Lafeber [Pays-Bas] ; Johannes Wg Jacobs [Pays-Bas] ; Paco Mj Welsing [Pays-Bas]Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
000B77 (2019) Ernest Choy [Royaume-Uni] ; Nick Freemantle [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Chieh-I Chen [États-Unis] ; Laurence Pollissard [France] ; Andreas Kuznik [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Erin Mangan [États-Unis] ; Paulo Carita [France] ; Thi-Minh-Thao Huynh [France]Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
000B83 (2019) Toshiyuki Watanabe [Japon] ; Jun Fukae [Japon] ; Shinji Fukaya [Japon] ; Norifumi Sawamukai [Japon] ; Masato Isobe [Japon] ; Megumi Matsuhashi [Japon] ; Masato Shimizu [Japon] ; Kazumasa Akikawa [Japon] ; Kazuhide Tanimura [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon]Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Polyarthrite rhumatoïde" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Polyarthrite rhumatoïde" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Polyarthrite rhumatoïde
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021